ArticleMalaria journal2026
First detection of pfhrp2 and pfhrp3 gene deletions in Niger Republic: a retrospective sub-analysis of biological samples.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid diagnostic tests (RDTs) based on histidine-rich protein 2 (HRP2) are the main diagnostic tool for malaria in Niger and many countries in sub-Saharan Africa. However, deletions of the P. falciparum hrp2 and hrp3 genes can compromise RDT performance, and pose a threat to diagnostic accuracy. Although these deletions were reported in several regions of Africa, Asia and South America, no molecular data on pfhrp2/3 were previously available for Niger.
methodsThe present study is a retrospective sub-analysis of biological samples derived from a therapeutic efficacy study (TES) conducted in Niger in 2022. Antigen profiling was performed using a multiplex bead-based assay to identify samples with weak or undetectable HRP2 signal. Species confirmation was conducted by PET-PCR, and pfhrp2/3 exon 2 genotyping was performed using one-step PCR.
resultsAmong the 375 P. falciparum mono-infection isolates analyzed, pfhrp2 deletions were found in 3% (11/375; 95% CI 1-5%), pfhrp3 deletions in 11% (41/375; 95% CI 8-14%), and double deletions in 1% (5/375; 95% CI 0-2%). These figures likely represent a conservative estimate, as the true prevalence may be higher due to the antigen pre-screening and the selection bias inherent in the original study design.
conclusionsThis is the first molecular evidence of Pfhrp2 and Pfhrp3 deletions in P. falciparum in Niger. The observed pfhrp2 deletion rate is a significant molecular finding; however, further evidence is needed to determine if the rate of false-negative RDTs caused by these deletions reaches the 5% threshold set by WHO for a national RDT policy revision.
Indexed as
Identifiers
42919259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.